This is the first sickle cell treatment to be recommended by the National Institute for Health and Care Excellence for routine use on the NHS.
Users of Voxelotor have shared with us remarkable stories of improved quality of life, reduced pain, and substantial increases in energy levels.
For today, we celebrate this milestone, and commend everyone who tirelessly contributed to it.
[
add
]
[
|
|
...
]